Cyclovirobuxine inhibits the progression of clear cell renal cell carcinoma by suppressing the IGFBP3-AKT/STAT3/MAPK-Snail signalling pathway
Yadong Liu(Harbin Medical University), Zhigang Wang(Dalian Medical University)
Cited by 40
Related Papers
ROS-responsive liposomes as an inhaled drug delivery nanoplatform for idiopathic pulmonary fibrosis treatment via Nrf2 signaling
|Journal of Nanobiotechnology|2022|125
Comprehensive dry eye therapy: overcoming ocular surface barrier and combating inflammation, oxidation, and mitochondrial damage
|Journal of Nanobiotechnology|2024|49